Navigation

🏠 Home 📰 Latest News 🌍 World 🇮🇳 India 💼 Business 💻 Technology ⚽ Sports 🎬 Entertainment 🏥 Health
Biggest News Aggregation in the World
📰 Key Clinical Development Programs News

Key Clinical Development Programs News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Key Clinical Development Programs. Real-time updates on events, politics, business and more.

© 2023 Tonix Pharmaceuticals Holding Corp. INVESTOR PRESENTATION NASDAQ: TNXP Version P04 88 September 25 , 2023 (Doc 1321 ) - Form 8-K -September 25, 2023 at 04:40 pm EDT

September 25, 2023
T ianeptine - tianeptine 1 Stablon. Summary of product characteristics. Les Laboratoires Servier Industrie ; 2014. 2 PubChem. Accessed November 10, 2022....
United States Dapirolizumab Letolizumab Aglycosyl Ruplizumab Cyclobenzaprine Protectic Clin Rheumatol Zembrace Symtouch Edward Jenner
Source: marketscreener.com

Horizon Therapeutics plc Reports Third-Quarter 2022 Financial Results; Increases Full-Year 2022 Net Sales and Adjusted EBITDA Guidance; Increases TEPEZZA and KRYSTEXXA Peak Annual Net Sales Expectations

November 2, 2022
Third-Quarter 2022 Results: -- Net Sales of $925.4 Million -- -- GAAP Net Income of $135.8 Million; Adjusted EBITDA of $335.3 Million, Which Includes $19.0 Million of Acquired IPR&D and Milestones
United States Geoff Curtis Tim Walbert Tina Ventura Ray Gordon Erin Linnihan
Source: finanznachrichten.de

Horizon Therapeutics plc Reports First-Quarter 2021 Financial Results; Updating Full-Year 2021 Net Sales Guidance and Full-Year Adjusted EBITDA Guidance to Incorporate Recently Acquired Viela Bio, Inc.

May 5, 2021
-- First-Quarter 2021 Net Sales of $342.4 Million; First-Quarter 2021 GAAP Net Loss of $123.4 Million; Adjusted EBITDA of $45.8 Million -- -- First-Quarter 2021 Orphan Segment Net Sales Increased
United States Viela Bio Ruth Venning Geoff Curtis Tim Walbert Tina Ventura
Source: finanznachrichten.de

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science